Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01599754
Title Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors SFJ Pharmaceuticals, Inc.
Age Groups: adult
Covered Countries USA | FRA | ESP

No variant requirements are available.